Wordt geladen...
Two Different Doses of Intravitreal Bevacizumab for Treatment of Choroidal Neovascularization Associated with Age-related Macular Degeneration
PURPOSE: To compare the efficacy and safety of 1.25 mg versus 2.5 mg intravitreal bevacizumab (IVB) for treatment of choroidal neovascularization (CNV) associated with agerelated macular degeneration (AMD). METHODS: In this randomized clinical trial, consecutive patients with active CNV associated w...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Ophthalmic Research Center
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3589230/ https://ncbi.nlm.nih.gov/pubmed/23479531 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|